The Omega-3 market is valued at USD 9,782.5 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period, to reach a value of USD 22,453.5 million by 2034.
Omega-3 sales growth shall be driven by innovations in omega-3 ingredients formulations, and increased consumer awareness of the relationship between their immunity digestive health, and overall wellbeing.
Moreover, the governments of various countries such as the USA, Sweden, Canada, and Japan are taking initiatives and promoting adequate intake of omega-3 fatty acids due to potential health benefits. This is expected to create new opportunities for players operating in the global omega 3 ingredients market
| Attributes | Key Insights |
|---|---|
| Omega-3 Market Size (2024E) | USD 9,782.5 million |
| Omega-3 Market Projected Size (2034F) | USD 22,453.5 million |
| Value CAGR (2024 to 2034) | 8.7% |
| Top 3 Countries Market Share | 33.1% |
Increasing preference for mono & poly-unsaturated fatty acids owing to excessive consumption of saturated fat increases risk of coronary heart diseases (CHD), stroke or cardiovascular diseases (CVD).
As polyunsaturated fatty acids (PUFAs) reduces risks of developing heart diseases. Replacing saturated and trans fats in regular diet with heart-healthy mono- and poly-unsaturated fats, helps to lower LDL cholesterol levels and decreases the risk of developing cognitive impairment among adults
American Heart Association (AHA) recommends consumption of polyunsaturated fats (PUFAs) in regular diet to reduce risks associated with heart disease and avoid diets with saturated fat and trans fat. Moreover, PUFAs provide nutrients to develop and maintain body cells. In addition, AHA also recommends consumption of tofu, soybean, flaxseed, canola, walnut and their oils, owing to these foods being rich in alpha-linolenic acid (ALA).
PUFAs can be extracted from both plant and marine sources. Plant sources include chia seed oil, flax seed oil, soybean oil, canola oil, walnut oil and mustard oil among others. Marine sources comprise algal, fungus oil, fish oil (salmon, tuna, and herring) and krill oil.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particular | Value CAGR |
|---|---|
| H1 | 8.9% (2023 to 2033) |
| H2 | 8.5% (2023 to 2033) |
| H1 | 8.6% (2024 to 2034) |
| H2 | 8.7% (2024 to 2034) |
The above table presents the expected CAGR for the global Omega-3 industry over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 8.9%, followed by a slightly lower growth rate of 8.5% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 8.6% in the first half and remain relatively moderate at 8.7% in the second half. In the first half (H1) the industry witnessed a decrease of 30 BPS while in the second half (H2), the industry witnessed an increase of 20 BPS
High Prevalence of Chronic Diseases Coupled With Rising Awareness about PUFAs as a Preventive Solution
According to the WHO, cardiovascular diseases are the leading cause of death globally. In 2019, CVDs were responsible for 32% of all fatalities worldwide, resulting in approximately 17.9 million deaths.
Heart attacks and strokes accounted for 85% of these fatalities, with over 75% occurring in low- and middle-income nations. Noncommunicable diseases, including CVDs, caused 17 million premature deaths (deaths under 70 years of age) in 2019, with 38% of these due to CVDs.
Most cardiovascular illnesses can be prevented by addressing behavioral risk factors such as tobacco use, poor diet, obesity, physical inactivity, and problematic alcohol consumption. Early detection of cardiovascular illness is crucial for the initiation of medication and counseling-based therapy.
Due to the rising risk of CVDs, awareness about the benefits of consuming polyunsaturated fatty acids (PUFAs) is increasing among consumers in Asia, North America, and Western Europe.
Research has shown that fish oil, rich in PUFAs, helps reduce symptoms of ADHD in children and improves their mental skills. PUFAs, such as omega-3 and omega-6 fatty acids, are essential fats not produced by the human body and must be consumed through supplements or capsules. These fatty acids help decrease LDL cholesterol levels in individuals.
A recent survey published in the Nutrition Business Journal (NBJ) reported that 94% of consumers were aware of omega-3, a significant increase from 54% in 1999. Additionally, PUFAs have been found to boost the effects of antidepressants and assist in the treatment of bipolar disorder. Various studies also highlight the important role of PUFAs in the visual and neurological development of infants.
Increasing Usage Of Polyunsaturated Fats In Infant Formula, Nutritional Products And Adult Dietary Supplements
The increasing shift in consumer preference for dietary supplements containing polyunsaturated fatty acids (PUFAs) over other functional food ingredients is expected to drive the growth of the global Omega-3 industry in the coming years. The consumption of PUFAs in infant formula products is rising due to their visual and neurological development benefits for infants.
Consumers in the USA, Europe, and Japan are becoming more proactive in self-care and using nutritional supplements to maintain health and reduce the risk of illnesses, which is anticipated to boost the global PUFAs industry.
Various international health organizations, such as the American Heart Association (AHA) and the Council for Responsible Nutrition (CRN), have acknowledged the potential benefits of fish oil containing omega-3 fatty acids, particularly EPA and DHA.
Recent studies and publications continue to support the role of omega-3 fatty acids in reducing the risk of chronic diseases such as coronary heart disease (CHD). For instance, a 2022 meta-analysis published in the Journal of the American Heart Association confirmed that regular consumption of EPA and DHA significantly lowers the risk of CHD.
Omega-3 products are gaining traction worldwide, attributed to their increasing application in the food and beverage, pharmaceutical, and aquaculture industries.
Extensive research, including recent medical and clinical trials by ingredient suppliers and independent organizations, coupled with rising awareness about the health benefits of PUFAs in reducing risks associated with conditions like asthma and attention deficit hyperactivity disorder (ADHD), are key factors expected to drive sales revenue of the omega-3 ingredients industry in the near future.
Adoption of Innovative Marketing Strategies and Advanced Processing Technologies
The adoption of innovative marketing strategies has significantly boosted the growth of participants in the omega-3 ingredients industry. Manufacturers have invested heavily at each stage of product development to increase awareness about the health benefits of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA).
To enhance awareness, they have shared successful clinical trial results with their target customers. Given the highly regulated nature of the EPA, DHA, and ALA industry, the specific qualities of the products determine their positioning and targeted applications.
Omega-3 ingredient manufacturers have effectively marketed their products to highlight their numerous benefits. For example, EPA and DHA are increasingly used in dietary supplements and infant formulas due to their versatile characteristics.
Besides being adaptable ingredients, omega-3s offer various health benefits, making them popular, especially among the elderly who are more health-conscious and looking to reduce healthcare costs by using these supplements.
To expand production capacity, manufacturers have adopted advanced processing technologies. Microencapsulation technology, for instance, is used to incorporate fish oils rich in omega-3s into food products, enhancing their palatability and stability. Microencapsulated fish oil powders or stable fish oil-enriched products are commonly used in infant formulas, dietary supplements, and food and beverages.
An example of innovation in this field is Polaris Nutritional Lipids' development of QUALITYSILVER, a technology designed to prevent oil oxidation, thereby protecting its nutritional and sensory qualities. This technology extends the shelf life and improves the stability of the omega-3 oils, making the products more reliable and effective.
Principal Consultant
Omega-3 demand grew at an 8.3% CAGR between 2019 and 2023. Looking ahead, the forecast for 2024 to 2034 indicates an even stronger growth trajectory, driven by several key factors.
Increasing consumer awareness about the health benefits of omega-3 fatty acids is a major driver. With more people understanding the importance of omega-3s for heart health, cognitive function, and inflammation reduction, the demand for omega-3 supplements is expected to rise significantly. This awareness is further fueled by extensive marketing campaigns and educational initiatives by industry players.
The expanding applications of omega-3s in various industries are also contributing to this positive outlook. Beyond dietary supplements, omega-3s are increasingly being incorporated into functional foods and beverages, infant formulas, and even pet nutrition products. This diversification is opening up new avenues for industry growth.
The rising prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and arthritis, is another critical factor. As more individuals seek preventive healthcare solutions, the demand for omega-3 supplements, known for their role in managing and reducing the risk of these conditions, is expected to surge.
Additionally, the aging global population, particularly in regions like North America, Europe, and parts of Asia, is turning to omega-3 supplements to maintain overall health and wellness, further boosting demand.
Advancements in processing technologies and innovative product formulations are also driving industry growth. Technologies such as microencapsulation are improving the stability and palatability of omega-3 products, making them more appealing to a broader range of consumers. Innovations in delivery methods, such as gummies, soft gels, and functional foods, are making omega-3 consumption more convenient and enjoyable.
Strategic marketing initiatives by manufacturers play a crucial role in promoting the benefits of EPA, DHA, and ALA. Companies are leveraging digital marketing, influencer partnerships, and clinical trial results to build consumer trust and highlight the scientific backing of their products. This strategic approach is enhancing brand loyalty and driving sales.
Regulatory support and endorsements from health organizations such as the American Heart Association (AHA) and the Council for Responsible Nutrition (CRN) are also influential. These endorsements lend credibility to omega-3 products and reassure consumers about their safety and efficacy, encouraging more people to incorporate omega-3 supplements into their daily routines.
The global Omega-3 industry is characterized by the presence of a large number of multinational and regional companies. Approximately 70-75% of the comapny share is held by multinational players, who offer a wide range of products. These companies primarily target Europe and North America, regions known for their high number of health-conscious consumers.
Major multinational companies operating in the Omega-3 industry include Cargill Incorporated, Croda International Plc, Koninklijke DSM N.V., and Omega Protein Corporation.
Regional and local players account for the remaining company share, with regional companies holding about 20-25% and local players 5-10%. These players operate across various regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. They focus on both domestic and international sales, striving to meet the growing demand for Omega-3 products worldwide.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The following table shows the estimated growth rates of the top five geography sales. China and India are set to exhibit high Ginseng Extract consumption, recording CAGRs of 11.5% and 10.4%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| United States | 7.6% |
| Germany | 8.6% |
| China | 11.5% |
| Australia | 9.1% |
| India | 10.4% |
Research conducted by Eurostat indicates that approximately 7.2% of Europeans are grappling with chronic depression, with Portugal leading with a share of 12.3%. There's a concern among researchers that these numbers might escalate in the future. In response, many Europeans are turning to omega-3-rich foods to support their mental health. EPA, a type of omega-3, is particularly popular among Europeans looking to incorporate this nutrient into their diets.
In the United States, heart disease stands as the leading cause of death for both men and women, as revealed by a survey from the Centers for Disease Control and Prevention. Shockingly, the statistics show that one person succumbs to heart disease every 34 seconds in the USA.
To address this concerning trend, medical professionals are advocating for increased consumption of omega-3-rich foods. Omega-3 fatty acids play a crucial role in maintaining arterial health by preventing damage and inhibiting the formation of plaque, which can lead to arterial hardening.
In South Korea, stroke emerges as the primary cause of mortality, according to statistics compiled by healthdata.org. Additionally, there has been a notable surge of nearly 75% in Alzheimer’s disease cases between 2009 and 2019. In response to these alarming health trends, South Koreans are increasingly incorporating omega-3 into their regular diets.
Whether combating stroke or Alzheimer's, omega-3 appears to offer potential solutions to a range of health issues. Particularly noteworthy is its effectiveness in addressing Alzheimer's disease at its early stages.
| Segment | Product Type (DHA) |
|---|---|
| Value Share (2024) | 46.5% |
Based on the type, the DHA segment is expected to have the largest value share during the forecast period. This is mainly owing to the fact that DHA is effective in treating cardiac illnesses. Furthermore, DHA has also been instrumental in maintaining a normal range of BP.
Apart from that, the DHA is effective in lowering the triglycerides level, which may otherwise lead to an increase in bad cholesterol. Furthermore, attention-based deficiencies can be treated using DHA.
| Segment | Source (Marine) |
|---|---|
| Value Share (2024) | 68.6% |
Based on the source, the marine category is expected to hold the largest market share during the forecast period. Omega 3 is obtained from fish. Apart from that, omega-3 fatty acids are also obtained from salmon, tuna, sardines, etc.
Being a rich source of DHA and EPA, fish oil is mainly used for treating heart disorders. Additionally, the capability to control the growth of arterial plaque is expected to further surge the growth of this category.
Companies operating in the arrena are trying and intending to operate and construct commercial facilities to produce omega-3 fatty acids as integrated algae-based, canola-based, fish-based, or krill-based bio-refineries.
This enables companies to significantly control their entire supply chain, and avoid uncertainties in prices and the quality of raw materials. Thus, more and more companies are following this business structure to gain an advantage in the essential fatty acids industry.
As per product type the industry has been categorized into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), Alpha-linolenic acid (ALA)
The segment is further categorized into Marine Source and Plant Source
End-Use in further categorized into Nutraceuticals & Supplements, Food & Beverages, Pharmaceuticals, Personal Care, Infant Formulas, Fish Feed Others
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa
The Omega-3 sales is estimated to reach sales nearly USD 9,782.5 Million by 2024.
Omega-3 industry revenue is expected to increase at a CAGR of around 8.7% during the period 2024-2034.
Omega-3 sales increased a CAGR of around 8.3% over the past half-decade.
The global Omega-3 industry value will be around USD 22,453.5 Million in 2034.
Croda International Plc, Omega Protein Corporation , Koninklijke DSM N.V. , Cargill Inc. , Epax Norway AS, GC Rieber Oils AS ,Pharma Marine AS, Copeinca ASA are expected to be the top players driving the industry growth.
Top countries driving the Omega-3 demand are South Korea, China, India, Japan, and the USA.
Innovative applications, research formulations, and medicinal properties are the factors driving growth of Omega-3 market.
1. Executive Summary
2. Industry Introduction, Including Taxonomy and Market Definition
3. Market Trends and Success Factors, Including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
6.1. Product Type
6.2. Source
6.3. End-use
6.4. Region
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product Type
7.1. Docosahexaenoic acid (DHA)
7.2. Eicosapentaenoic acid (EPA)
7.3. Alpha-linolenic acid (ALA)
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Source
8.1. Marine Source
8.2. Plant Source
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End-use
9.1. Nutraceuticals & Supplements
9.2. Food & Beverages
9.3. Pharmaceuticals
9.4. Personal Care
9.5. Infant Formulas
9.6. Fish Feed
9.7. Others
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
10.1. North America
10.2. Latin America
10.3. Europe
10.4. East Asia
10.5. South Asia
10.6. Oceania
10.7. Middle East and Africa
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Oceania Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Product Type, Source, and End-use for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
20.1. Croda International Plc
20.2. Omega Protein Corporation
20.3. Koninklijke DSM N.V.
20.4. Cargill Inc.
20.5. Epax Norway AS
20.6. GC Rieber Oils AS
20.7. Pharma Marine AS
20.8. Copeinca ASA
20.9. Arista Industries Inc.
20.10. Polaris Nutritional Lipids
20.11. Clover Corp. Ltd.
20.12. Marine Ingredients LLC
20.13. Others
Explore Food and Beverage Insights
View Reports
Omega-3 Market
